Natural Health Trends (NHTC) Q3 2026 earnings summary

Executive summary

• Q3 net sales were $7.56M, flat QoQ and down 20% YoY; operating loss narrowed 57% QoQ to $277K and net loss was $232K.

• Active Members totaled 27,040 at September 30, up from 26,000 at June 30 but below 28,030 a year earlier.

• Consumer caution, China uncertainty and member-network disruption weighed on sales; lower-priced packages and incentives supported sequential membership and revenue stability.

Financial highlights

• Q3 net sales were $7.56M vs. $9.48M; gross profit was $5.606M vs. $6.987M, and operating loss was $277K vs. $495K.

• Q3 net loss was $232K, or $0.03/share, vs. $431K, or $0.04/share; Q2 net loss was $451K, or $0.05/share.

• 9M net sales were $24.37M vs. $30.03M; operating loss was $1.394M vs. $1.173M, and net loss was $837K vs. $294K.

• Q3 SG&A was $3.2M, down $433K YoY; 9M SG&A fell $1.0M to $9.9M, reflecting lower employee, professional-fee and facilities costs.

Outlook and guidance

• Priorities include financial discipline, targeted investment, innovative products, digital tools, field engagement and growth and profitability.

• Move Prime was planned for launch in the coming weeks; a traditional Chinese medicine product for China was in development for introduction in coming months.

• Restructuring is expected to generate ~$1.5M in annualized savings; not all savings are expected in 2026, and timing and amount may vary.

• Weekly commissions are expected to remain below historical levels in the near term; existing liquidity and operating cash flows are expected to fund normal operations and commitments.